Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

S 2625: Relates to enhancing patient access to medication assisted treatment for treatment of opioid disease

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

S 2625 is a bill introduced in the New York Senate on January 21, 2025. According to its official title, it concerns: Relates to enhancing patient access to medication assisted treatment for treatment of opioid disease. Primary sponsor: Nathalia Fernández (Democratic). Most recent recorded action (March 17, 2026): REPORTED AND COMMITTED TO HIGHER EDUCATION.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Allows a licensed pharmacist to prescribe and order FDA-approved medication assisted therapy under a non-patient-specific regimen for the treatment of opioid use disease.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Nathalia FernándezPrimary sponsorDemocraticSenate34

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REPORTED AND COMMITTED TO HIGHER EDUCATION
  2. REFERRED TO HEALTH
  3. REPORTED AND COMMITTED TO FINANCE
  4. REFERRED TO HEALTH

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source